BDBM498050 US11008314, Compound 133

SMILES Cc1cc(C)c(cc1Sc1cnc(Nc2ccccn2)s1)C(=O)N1CCN(CC1)C(=O)C=C

InChI Key InChIKey=WZQABGJOXOHIMK-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 498050   

TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498050(US11008314, Compound 133)
Affinity DataIC50: <10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498050(US11008314, Compound 133)
Affinity DataIC50:  55nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498050(US11008314, Compound 133)
Affinity DataIC50:  55nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase TXK(Homo sapiens (Human))
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498050(US11008314, Compound 133)
Affinity DataIC50: <10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent